Creative Planning Shockwave Medical, Inc. Transaction History

Creative Planning

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$191.17 - $325.63 $46,645 - $79,453	244 Added 12.82%	2,148 $699,000
Q4 2023 Feb 14, 2024	SELL	$160.99 - $215.69 $96,915 - $129,845	-602 Reduced 24.02%	1,904 $362,000
Q3 2023 Nov 16, 2023	SELL	$194.33 - $283.97 $91,918 - $134,317	-473 Reduced 15.88%	2,506 $498,000
Q2 2023 Jul 21, 2023	BUY	$223.05 - $302.68 $221,042 - $299,955	991 Added 49.85%	2,979 $850,000
Q1 2023 May 15, 2023	BUY	$175.41 - $217.92 $127,347 - $158,209	726 Added 57.53%	1,988 $431,000
Q4 2022 Feb 10, 2023	SELL	$204.38 - $296.82 $25,343 - $36,805	-124 Reduced 8.95%	1,262 $259,000
Q3 2022 Nov 03, 2022	BUY	$195.21 - $310.53 $270,561 - $430,394	1,386 New	1,386 $385,000

321K

1.9K

Ticker SWAV
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,927,100
Description
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

Stay updated on Creative Planning with notifications on news.